W. Zin (Rio De Janeiro, Brazil), O. Pedersen (Aarhus, Denmark)
Interactions between acetylcholine and apelin 13/urotensin II in rat left main bronchial rings
I. L. Dumiriu, B. Gurzu, A. Costuleanu, E. Cojocaru, S. M. Slatineanu, M. Costuleanu, G. Ptrescu (Iasi, Romania)
|  |
The linkage of bronchial hyperreactivity with Arg16Gly and Gln27Glu polymorphisms of ß2-adrenoreceptors of patients with atopic bronchial asthma in Kyrgyz nation
T. M. Sooronbaev, A. K. Kurenkeeva, A. A. Aldashev, O. A. Pak, M. M. Mirrakhimov (Bishkek, Kyrgyzstan)
| |
Expression of cyclooxygenases and prostaglandinreceptors in pulmonary chondrohamartoma
C. Brochhausen, F. Crasselt, A. Schad, R. M. Nusing, C. J. Kirkpatrick (Mainz, Frankfurt/Main, Germany)
| |
The effect of corticosteroids on pleurodesis induced by iodopovidone in rabbits
Y. Guo, C. Xie, S. Bilaceroglu, I. Kalomenidis, K. B. Lane, R. W. Light (Guangzhou, China; Nashville, United States Of America)
| |
N-acetylcysteine attenuates the stress oxidative induced by chronic paraquat toxicity in different tissues
J. A. Magalhães, A. Caldas, G. C. Almeida, A. P. B. Campos-Nunes, J. F. Pinho, V. S. Lemos, L. S. A. Capettini, M. V. Caliari, W. A. Zin, M. D. G. Rodrigues-Machado (Belo Horizonte, Rio de Janeiro, Brazil)
| |
Oxidative stress and antioxidative defense in the pulmonary complications of acute pancreatitis: the possibilities of correction
A. Perejaslov, S. Chooklin, I. Bihalskyy, R. Vatseba (Lviv, Uzbekistan)
| |
Sputum matrix metalloproteinase-9 and tissue inhibitor of matrix metalloprotienase-1 levels in patients with COPD
N. Ucar, B. A. Dursun, S. Alpar, B. Kurt, M. Atasever (Ankara, Bolu, Turkey)
| |
Sildenafil treatment for portopulmonary hypertension
F. Reichenberger, R. Vosswinckel, B. Enke, E. Steveling, A. Kreckel, H. Gall, M. Thamm, H. Olschewski, F. Grimminger, W. Seeger, H. A. Ghofrani (Giessen, Germany; Graz, Austria)
| |
Plasma 6-ketoPGF1α, a stable metabolite of prostaglandin I2 shows a marked decrease in patients with COPD
Y. Nakano, Y. Chiba, S. Kitamura (Oyama City, Japan)
| |
Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients
M. Michailidou, N. Rovina, E. Dima, D. Simoes, C. Roussos, C. Gratziou (Athens, Greece)
| |
Exhaled nitric oxide concentration and exhaled breath condensate pH after hyperbaric oxygen exposure
T. Taraldsoy, B. Bolann, T. B. Aasen, E. Thorsen (Bergen, Norway)
| |
Endothelial dysfunction as systemic effects of COPD
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Bronchial blood flow is normal in COPD patients and is positevily correlated with exhaled nitric oxide and the diffusion of carbon monoxide
P. Paredi, S. Ward, G. Invernizzi, D. Cramer, P. J. Barnes, S. A. Kharitonov (London, United Kingdom; Prata Camportaccio, Italy)
| |
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
N. Rovina, A. Papapetropoulos, M. Michailidou, A. Kollintza, D. Simoes, C. Roussos, C. Gratziou (Athens, Greece)
| |
Pulmonary cachexia and the oxidant/antioxidant balance
E. M. Mercken, G. J. Hageman, J. M. J. Houben, H. J. Moonen, R. Broekhuizen, A. Bast, E. F. M. Wouters, A. M. W. J. Schols (Maastricht, Netherlands)
| |
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
N. Rovina, A. Papapetropoulos, M. Michailidou, A. Kollintza, D. Simoes, C. Roussos, C. Gratziou (Athens, Greece)
| |
Extended NO analysis in a healthy subgroup in a random sample population
M. Högman, J. Lafih, K. Bröms, T. Holmkvist, A. Malinovschi, C. Janson, P. Meriläinen (Uppsala, Gavle, Sweden)
| |
Airway: blood glucose ratio. A new pulmonary biomarker?
E. H. Baker, N. Clark, D. A. Fisher, K. M. Gyi, D. M. Wood, M. E. Hodson, D. M. Geddes, D. L. Baines, B. J. Philips, A. L. Brennan (London, United Kingdom)
| |